Crossref journal-article
Elsevier BV
Bioorganic & Medicinal Chemistry (78)
Bibliography

Robarge, K. D., Dina, M. S., Somers, T. C., Lee, A., Rawson, T. E., Olivero, A. G., Tischler, M. H., Webb, R. R., Weese, K. J., Aliagas, I., & Blackburn, B. K. (1998). Preparation and biological activity of novel tricyclic GPIIb/IIIa antagonists. Bioorganic & Medicinal Chemistry, 6(12), 2345–2381.

Authors 11
  1. Kirk D. Robarge (first)
  2. Michael S. Dina (additional)
  3. Todd C. Somers (additional)
  4. Arthur Lee (additional)
  5. Thomas E. Rawson (additional)
  6. Alan G. Olivero (additional)
  7. Maureen H. Tischler (additional)
  8. Robert R. Webb (additional)
  9. Kenneth J. Weese (additional)
  10. Ignacio Aliagas (additional)
  11. Brent K. Blackburn (additional)
References 45 Referenced 13
  1. 10.1182/blood.V71.4.831.831 / Blood by Phillips (1988)
  2. 10.1182/blood.V55.5.841.841 / Blood by Peerschke (1980)
  3. 10.1161/01.CIR.71.4.699 / Circulation by Falk (1985)
  4. 10.1056/NEJM199001043220107 / New Engl. J. Med. by Coller (1990)
  5. {'key': '10.1016/S0968-0896(98)80013-8_BIB6', 'first-page': '515', 'author': 'Cadroy', 'year': '1990'} by Cadroy (1990)
  6. 10.1007/BF00320567 / Blut by Scharf (1987)
  7. {'key': '10.1016/S0968-0896(98)80013-8_BIB8', 'first-page': '533', 'volume': '1', 'author': 'Zablocki', 'year': '1995', 'journal-title': 'Curr. Pharm. Des.'} / Curr. Pharm. Des. by Zablocki (1995)
  8. 10.1016/S0021-9258(17)42338-6 / J. Biol. Chem. by Farrell (1994)
  9. 10.1182/blood.V88.8.2967.bloodjournal8882967 / Blood by Zaidi (1996)
  10. 10.1358/dof.1994.019.05.595580 / Drugs Future by Weller (1994)
  11. 10.1016/S0065-7743(08)60409-1 / J. Ann. Rept. Med. Chem. by Jakubowski (1992)
  12. 10.1016/S0065-7743(08)60879-9 / Ann. Rept. Med. Chem. by Blackburn (1993)
  13. {'key': '10.1016/S0968-0896(98)80013-8_BIB14', 'first-page': '135', 'volume': '19', 'author': 'Cook', 'year': '1994', 'journal-title': 'Drugs Future'} / Drugs Future by Cook (1994)
  14. 10.1021/ja00091a008 / J. Am. Chem. Soc. by McDowell (1994)
  15. 10.1358/dof.1994.019.08.595796 / Drugs Future by Austel (1994)
  16. 10.1056/NEJM199506083322306 / New Engl. J. Med. by Lefkovits (1995)
  17. 10.1021/jm960210f / J. Med. Chem. by Stilz (1996)
  18. 10.1021/jm00065a003 / J. Med. Chem. by Zablocki (1993)
  19. 10.1021/jm00101a017 / J. Med. Chem. by Alig (1992)
  20. 10.1021/bi00433a025 / Biochemistry by Kloczewiak (1989)
  21. 10.1021/jm00089a014 / J. Med. Chem. by Barker (1992)
  22. 10.1021/ja00050a049 / J. Am. Chem. Soc. by Kopple (1992)
  23. 10.1021/jm00099a026 / J. Med. Chem. by Peishoff (1992)
  24. 10.1021/ja00087a006 / J. Am. Chem. Soc. by Bach (1994)
  25. {'key': '10.1016/S0968-0896(98)80013-8_BIB27', 'author': 'Hann', 'year': '1992'} by Hann (1992)
  26. U.S. Patent 5,705,890 1998. The tricyclic inhibitors were designed to be out of the scope covered in PCT/US92/05463 (WO 93/00095) titled Bicyclic Fibrinogen Antagonists.
  27. 10.1016/0960-894X(95)00057-Z / Bioorg. Med. Chem. Lett. by Askew (1995)
  28. 10.1016/S0960-894X(01)80380-2 / Bioorg. Med. Chem. Lett. by Egbertson (1994)
  29. 10.1016/S0960-894X(01)80381-4 / Bioorg. Med. Chem. Lett. by Naylor (1994)
  30. 10.1021/jm00049a006 / J. Med. Chem. by Eldred (1994)
  31. 10.1021/ja00072a058 / J. Am. Chem. Soc. by Ku (1993)
  32. 10.1021/jm00385a011 / J. Med. Chem. by Jones (1987)
  33. 10.1021/jm00385a012 / J. Med. Chem. by Venuti (1987)
  34. 10.1021/jm00130a010 / J. Med. Chem. by Watjen (1989)
  35. 10.1021/jo00384a062 / J. Org. Chem. by Bock (1987)
  36. Freidinger, R. M. EP 0 519 678 A2.
  37. 10.1021/jo00007a027 / J. Org. Chem. by Duncia (1991)
  38. 10.1021/jm960652r / J. Med. Chem. by Blackburn (1997)
  39. {'key': '10.1016/S0968-0896(98)80013-8_BIB43', 'author': 'Tsuji', 'year': '1980'} by Tsuji (1980)
  40. {'key': '10.1016/S0968-0896(98)80013-8_BIB44', 'author': 'Heck', 'year': '1985'} by Heck (1985)
  41. 10.1016/S0040-4020(01)96753-5 / Tetrahedron by Cava (1985)
  42. 10.1016/S0040-4039(00)78862-9 / Tetrahedron Lett. by Foloppe (1992)
  43. 10.1021/jo00317a045 / J. Org. Chem. by Baxter (1981)
  44. Presented at the 214th National ACS Convention, Las Vegas, Nevada. Abstract 27, MEDI.
  45. {'key': '10.1016/S0968-0896(98)80013-8_BIB49', 'author': 'Frisch', 'year': '1995'} by Frisch (1995)
Dates
Type When
Created 22 years, 10 months ago (Oct. 11, 2002, 12:45 p.m.)
Deposited 4 years, 3 months ago (May 11, 2021, 5:57 p.m.)
Indexed 1 year, 10 months ago (Oct. 16, 2023, 10:31 a.m.)
Issued 26 years, 8 months ago (Dec. 1, 1998)
Published 26 years, 8 months ago (Dec. 1, 1998)
Published Print 26 years, 8 months ago (Dec. 1, 1998)
Funders 0

None

@article{Robarge_1998, title={Preparation and biological activity of novel tricyclic GPIIb/IIIa antagonists}, volume={6}, ISSN={0968-0896}, url={http://dx.doi.org/10.1016/s0968-0896(98)80013-8}, DOI={10.1016/s0968-0896(98)80013-8}, number={12}, journal={Bioorganic & Medicinal Chemistry}, publisher={Elsevier BV}, author={Robarge, Kirk D. and Dina, Michael S. and Somers, Todd C. and Lee, Arthur and Rawson, Thomas E. and Olivero, Alan G. and Tischler, Maureen H. and Webb, Robert R. and Weese, Kenneth J. and Aliagas, Ignacio and Blackburn, Brent K.}, year={1998}, month=dec, pages={2345–2381} }